Exports In 2023, Belgium exported $1.86B in Nucleic Acids, making it the 6th largest exporter of Nucleic Acids in the world. At the same year, Nucleic Acids was the 33rd most exported product in Belgium. The main destination of Nucleic Acids exports from Belgium are: Italy ($1.05B), France ($158M), United States ($139M), Japan ($97.3M), and Ireland ($86.4M).
The fastest growing export markets for Nucleic Acids of Belgium between 2022 and 2023 were Italy ($541M), France ($48.7M), and Spain ($19M).
Imports In 2023, Belgium imported $587M in Nucleic Acids, becoming the 10th largest importer of Nucleic Acids in the world. At the same year, Nucleic Acids was the 122nd most imported product in Belgium. Belgium imports Nucleic Acids primarily from: Germany ($99.1M), Portugal ($93.9M), United States ($92.8M), Singapore ($88.2M), and Ireland ($80.7M).
The fastest growing import markets in Nucleic Acids for Belgium between 2022 and 2023 were Portugal ($93.9M), South Korea ($7.82M), and Singapore ($5.82M).
COMPANIES In 2023, leading companies such as Givaudan Fragrances (6), Volvo (4), and Mercedes-Benz (4) were at the forefront of shipping Nucleic Acids from Belgium to the United States.